BioAdvance News

Galleon Pharmaceuticals Names Joseph Oliveto as Chief Executive Officer

By WebmasterAugust 4, 2015November 1st, 2024No Comments

Galleon Pharmaceuticals Names Joseph Oliveto as Chief Executive Officer
Read more here

Previous PostMD Revolution and WellTrackONE Partner to Prepare Renaissance Health Network for Value Based Care
Next PostBioAdvance Portfolio Companies Attract $85 Million of Capital in 12 Months